302 related articles for article (PubMed ID: 22923367)
1. Recent advances in α-synuclein functions, advanced glycation, and toxicity: implications for Parkinson's disease.
Guerrero E; Vasudevaraju P; Hegde ML; Britton GB; Rao KS
Mol Neurobiol; 2013 Apr; 47(2):525-36. PubMed ID: 22923367
[TBL] [Abstract][Full Text] [Related]
2. The deglycase activity of DJ-1 mitigates α-synuclein glycation and aggregation in dopaminergic cells: Role of oxidative stress mediated downregulation of DJ-1 in Parkinson's disease.
Sharma N; Rao SP; Kalivendi SV
Free Radic Biol Med; 2019 May; 135():28-37. PubMed ID: 30796974
[TBL] [Abstract][Full Text] [Related]
3. DNA induced folding/fibrillation of alpha-synuclein: new insights in Parkinson's disease.
Hegde ML; Vasudevaraju P; Rao KJ
Front Biosci (Landmark Ed); 2010 Jan; 15(2):418-36. PubMed ID: 20036828
[TBL] [Abstract][Full Text] [Related]
4. Alpha-Synuclein Glycation and the Action of Anti-Diabetic Agents in Parkinson's Disease.
König A; Vicente Miranda H; Outeiro TF
J Parkinsons Dis; 2018; 8(1):33-43. PubMed ID: 29480231
[TBL] [Abstract][Full Text] [Related]
5. Challenges and complexities of alpha-synuclein toxicity: new postulates in unfolding the mystery associated with Parkinson's disease.
Hegde ML; Jagannatha Rao KS
Arch Biochem Biophys; 2003 Oct; 418(2):169-78. PubMed ID: 14522588
[TBL] [Abstract][Full Text] [Related]
6. Modulation of alpha-synuclein aggregation by dopamine: a review.
Leong SL; Cappai R; Barnham KJ; Pham CL
Neurochem Res; 2009 Oct; 34(10):1838-46. PubMed ID: 19444607
[TBL] [Abstract][Full Text] [Related]
7. Membrane interactions of oligomeric alpha-synuclein: potential role in Parkinson's disease.
van Rooijen BD; Claessens MM; Subramaniam V
Curr Protein Pept Sci; 2010 Aug; 11(5):334-42. PubMed ID: 20423294
[TBL] [Abstract][Full Text] [Related]
8. DJ-1 Acts as a Scavenger of α-Synuclein Oligomers and Restores Monomeric Glycated α-Synuclein.
Atieh TB; Roth J; Yang X; Hoop CL; Baum J
Biomolecules; 2021 Oct; 11(10):. PubMed ID: 34680099
[TBL] [Abstract][Full Text] [Related]
9. Glycation potentiates α-synuclein-associated neurodegeneration in synucleinopathies.
Vicente Miranda H; Szego ÉM; Oliveira LMA; Breda C; Darendelioglu E; de Oliveira RM; Ferreira DG; Gomes MA; Rott R; Oliveira M; Munari F; Enguita FJ; Simões T; Rodrigues EF; Heinrich M; Martins IC; Zamolo I; Riess O; Cordeiro C; Ponces-Freire A; Lashuel HA; Santos NC; Lopes LV; Xiang W; Jovin TM; Penque D; Engelender S; Zweckstetter M; Klucken J; Giorgini F; Quintas A; Outeiro TF
Brain; 2017 May; 140(5):1399-1419. PubMed ID: 28398476
[TBL] [Abstract][Full Text] [Related]
10. The role of advanced glycation end products in various types of neurodegenerative disease: a therapeutic approach.
Salahuddin P; Rabbani G; Khan RH
Cell Mol Biol Lett; 2014 Sep; 19(3):407-37. PubMed ID: 25141979
[TBL] [Abstract][Full Text] [Related]
11. Glycation in Parkinson's disease and Alzheimer's disease.
Vicente Miranda H; El-Agnaf OM; Outeiro TF
Mov Disord; 2016 Jun; 31(6):782-90. PubMed ID: 26946341
[TBL] [Abstract][Full Text] [Related]
12. Nitration and Glycation Diminish the α-Synuclein Role in the Formation and Scavenging of Cu
Martínez-Orozco H; Mariño L; Uceda AB; Ortega-Castro J; Vilanova B; Frau J; Adrover M
ACS Chem Neurosci; 2019 Jun; 10(6):2919-2930. PubMed ID: 30973706
[TBL] [Abstract][Full Text] [Related]
13. RAGE Against the Glycation Machine in Synucleinopathies: Time to Explore New Questions.
Gelain DP; Bittencourt RR; Bastos Mendes LF; Moreira JCF; Outeiro TF
J Parkinsons Dis; 2023; 13(5):717-728. PubMed ID: 37270812
[TBL] [Abstract][Full Text] [Related]
14. Alpha-Synuclein Nitration and Its Implications in Parkinson's Disease.
He Y; Yu Z; Chen S
ACS Chem Neurosci; 2019 Feb; 10(2):777-782. PubMed ID: 30183251
[TBL] [Abstract][Full Text] [Related]
15. Relationship between alpha synuclein phosphorylation, proteasomal inhibition and cell death: relevance to Parkinson's disease pathogenesis.
Chau KY; Ching HL; Schapira AH; Cooper JM
J Neurochem; 2009 Aug; 110(3):1005-13. PubMed ID: 19493164
[TBL] [Abstract][Full Text] [Related]
16. Role of advanced glycation on aggregation and DNA binding properties of α-synuclein.
Padmaraju V; Bhaskar JJ; Prasada Rao UJ; Salimath PV; Rao KS
J Alzheimers Dis; 2011; 24 Suppl 2():211-21. PubMed ID: 21441659
[TBL] [Abstract][Full Text] [Related]
17. Synergistic Amyloid Switch Triggered by Early Heterotypic Oligomerization of Intrinsically Disordered α-Synuclein and Tau.
Bhasne K; Sebastian S; Jain N; Mukhopadhyay S
J Mol Biol; 2018 Aug; 430(16):2508-2520. PubMed ID: 29704492
[TBL] [Abstract][Full Text] [Related]
18. Could α-synuclein amyloid-like aggregates trigger a prionic neuronal invasion?
Busquets MA; Espargaró A; Estelrich J; Sabate R
Biomed Res Int; 2015; 2015():172018. PubMed ID: 25866763
[TBL] [Abstract][Full Text] [Related]
19. Glycation of α-synuclein amplifies the binding with glyceraldehyde-3-phosphate dehydrogenase.
Semenyuk P; Barinova K; Muronetz V
Int J Biol Macromol; 2019 Apr; 127():278-285. PubMed ID: 30658140
[TBL] [Abstract][Full Text] [Related]
20. Alpha-synuclein oligomers: a new hope.
Bengoa-Vergniory N; Roberts RF; Wade-Martins R; Alegre-Abarrategui J
Acta Neuropathol; 2017 Dec; 134(6):819-838. PubMed ID: 28803412
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
